This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects | MicrobiomeTrials
← Back to trials NCT07421739
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects Recruiting OBSERVATIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-11-12Est. Completion: 2028-08-15
Enrollment target: 15 participantsLocations Eye Research Australia, East Melbourne, Victoria, Australia Other microbiome trials you might be interested in Radiation Retinopathy Visual Impairment
This randomized controlled trial will evaluate the effect of intravitreal faricimab or fluocinolone acetonide (FAc) intr…
Palo Alto, United States Est. completion Dec 26, 2029
Ciliary Body and Choroid Melanoma, Medium/Large Size Ciliary Body and Choroid Melanoma, Small Size Iris Melanoma Stage I Intraocular Melanoma Stage IIA Intraocular Melanoma Stage IIB Intraocular Melanoma
Stage IIIA Intraocular Melanoma
Stage IIIB Intraocular Melanoma
Stage IIIC Intraocular Melanoma
Stage I Uveal Melanoma AJCC V7
Stage II Uveal Melanoma AJCC V7
Stage III Uveal Melanoma AJCC V7
This randomized phase II trial studies how well sunitinib malate or valproic acid works in preventing high-risk uveal (e…
Philadelphia, United States Est. completion Dec 31, 2027